Successful long-term treatment with pazopanib after prior interleukin-2 therapy in patients with metastatic cutaneous angiosarcoma of the scalp

Dermatol Ther. 2020 Nov;33(6):e14007. doi: 10.1111/dth.14007. Epub 2020 Jul 26.

Authors

Miki Watanabe¹, Kozo Nakai¹, Yoshiko Iwaki¹, Toshiyuki Ozawa¹, Riei Kamo², Daisuke Tsuruta¹

Affiliations

¹ Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
² Division of Dermatology, Kashibaseiki Hospital, Kashiba, Japan.

PMID: 32654399
DOI: 10.1111/dth.14007

No abstract available

Publication types

Letter

MeSH terms

Hemangiosarcoma* / drug therapy
Humans
Indazoles
Interleukin-2
Pyrimidines
Scalp
Skin Neoplasms* / drug therapy
Sulfonamides

Substances

Indazoles
Interleukin-2
Pyrimidines
Sulfonamides
pazopanib